TRUE — Treatment.com AI Income Statement
0.000.00%
- CA$45.71m
- CA$43.96m
- 34
- 51
- 77
- 53
Annual income statement for Treatment.com AI, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3 | 2.91 | 13.8 | 3.77 | 3.9 |
Operating Profit | -3 | -2.91 | -13.8 | -3.77 | -3.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3 | -2.91 | -13.9 | -3.8 | -3.72 |
Net Income After Taxes | -3 | -2.91 | -13.9 | -3.8 | -3.72 |
Net Income Before Extraordinary Items | |||||
Net Income | -3 | -2.91 | -13.9 | -3.8 | -3.72 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3 | -2.91 | -13.9 | -3.8 | -3.72 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.102 | -0.44 | -2.15 | -0.584 | -0.155 |
Dividends per Share |